Dear Customer:

We would like to thank you for pioneering with R2 Technology, Inc. (R2), in bringing computer aided detection (CAD) to the field of mammography. With your adoption of the ImageChecker SL, the first FDA approved CAD system; you have truly helped set a new level of care in the fight against breast cancer.

Since the introduction of the Imagechecker SL in 1998, the clinical needs of most mammography practices have evolved, requiring greater efiiciencies in workflow and productivity. Due to this trend and the feedback from our customer base, we developed the ImegeChecker CL, which can take up to 20, four-film cases loaded at one time - a significant enhancement to workflow. The CL has become so popular, that it is now our basic configuration purchased by all of our customers today..

Due to this change in demand for greater workflow efficiencies, we have decided that the production of the ImageChecker SL should be discontinued and be replaced with the Imagechecker CL. We will, however, be providing current ImageChecker SL customers support throughout the next five years through your choice of service contracts, which can be purchased in increments of one, two or three years. If you choose to purchase a service contract, it will need to be signed and purchased before April 1, 2005. If you don't wish to take advantage of the R2 service contract, you may purchase parts and labor on an as needed base for the next five years.

R2 sees customers as partners for life, therefore as another alternative, which you may wish to consider, is a special offer to our Imagechecker SL customers to upgrade to an ImageChecker CL at an attractive discounted rate. For more information on the ImageChecker CL system, please contact your local R2 regional sales manager or call 866-CHECKED (243- 2533).

ImageChecker CL Features

  • 20 (4-film)-case load batch feed capability
  • Digital ready
  • Enhanced algorithm
  • OmniCAD Platform

Again, thank you for joining R2 in the eariy detection of breast cancer. We greatly appreciate, being part of your team in the fight againsl this deadly disease.

Best Regards,

Kevin Whiteley
Vice President, Marketing
Hologic, Inc.